ABOUT UC-NL CONSORTIUM

Our University of California National Laboratories Antiviral Treatments Targeting All Coronaviruses and Key RNA viruses (UC-NL ATTACK Consortium) is designed to develop safe and effective antivirals drugs to combat SARS-CoV-2 and other viruses of pandemic potential. Building on our novel science and technologies and our strong collaborations between investigators and industry partners, our Consortium has developed a robust and efficient pipeline that starts with discovery and ends with highly effective direct acting antiviral therapies that have met all the needed pre-clinical testing to enter human trials.